---
title: Groundbreaking
parent: Novelty
---

---

### **1. Value-judgement**  
Yes — strong positive evaluation.

<details markdown="1">
<summary><em>Examples</em></summary>

- *This **groundbreaking** study will be a model for similar efforts in other side effects of chemotherapy such as cognitive impairment …*

</details>

---

### **2. Hyperbolic**  
Yes — hyperbolic / exaggerated.

<details markdown="1">
<summary><em>Examples</em></summary>

- *We report **groundbreaking** findings that reshape current understanding of …*

</details>

---

### **3. Gratuitous**  
Often gratuitous unless the text makes clear what makes it “groundbreaking”.

<details markdown="1">
<summary><em>Examples</em></summary>

- *This **groundbreaking** work provides new insights into treatment response.*

</details>

---

### **4. Amplified**  
Can be amplified by boosters (e.g., *truly*, *highly*).

<details markdown="1">
<summary><em>Examples</em></summary>

- *This is a truly **groundbreaking** study in the field of …*

</details>

---

### **5. Coordinated**  
May be coordinated with other hype candidates (stacking).

<details markdown="1">
<summary><em>Examples</em></summary>

- *Our innovative and **groundbreaking** solution for identification of GAGs will dramatically increase the rate of uptake of NBS for more MPSs in state public health laboratories .*

</details>

---

### **6. Broader context**  
When ambiguous, check for nearby hype candidates or overt amplification.

<details markdown="1">
<summary><em>Examples</em></summary>

- *With our innovative tools and concepts , **groundbreaking** data and strong track record in MMP / TIMP and PNS research , we aim to study cellular and subcellular , including nuclear patterns of TIMP - 1 distribution , interactors and functions in PNS injury ( Aim 1 ) .*

</details>

[⬅ Back to Novelty](./index.md)
